EC Healthcare
UNHLF · OTC
9/30/2025 | 3/31/2025 | 9/30/2024 | 3/31/2024 | |
|---|---|---|---|---|
| Revenue | $247,983 | $2,077,315 | $2,062,897 | $2,089,722 |
| % Growth | -88.1% | 0.7% | -1.3% | – |
| Cost of Goods Sold | $205,149 | $1,505,806 | $1,384,487 | $1,423,491 |
| Gross Profit | $42,834 | $571,509 | $678,410 | $666,231 |
| % Margin | 17.3% | 27.5% | 32.9% | 31.9% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $127,728 | $126,716 | $111,050 |
| SG&A Expenses | $37,924 | $290,872 | $305,037 | $298,955 |
| Sales & Mktg Exp. | $0 | $84,904 | $92,565 | $99,723 |
| Other Operating Expenses | $4 | $0 | $0 | $0 |
| Operating Expenses | $37,928 | $290,872 | $305,037 | $637,793 |
| Operating Income | $4,906 | -$278,433 | $373,373 | $47,430 |
| % Margin | 2% | -13.4% | 18.1% | 2.3% |
| Other Income/Exp. Net | -$3,065 | $120,651 | -$316,731 | -$65,838 |
| Pre-Tax Income | $1,841 | -$157,782 | $56,642 | -$18,408 |
| Tax Expense | $1,299 | -$5,563 | $16,341 | $12,672 |
| Net Income | -$1,325 | -$181,283 | $14,097 | -$25,598 |
| % Margin | -0.5% | -8.7% | 0.7% | -1.2% |
| EPS | -0.001 | -0.15 | 0.012 | -0.022 |
| % Growth | 99.3% | -1,360.5% | 154.1% | – |
| EPS Diluted | -0.001 | -0.15 | 0.012 | -0.022 |
| Weighted Avg Shares Out | 1,185,211 | 1,184,856 | 1,185,219 | 1,163,545 |
| Weighted Avg Shares Out Dil | 1,185,211 | 1,185,211 | 1,185,211 | 1,185,211 |
| Supplemental Information | – | – | – | – |
| Interest Income | $988 | $0 | $0 | $25,734 |
| Interest Expense | $4,925 | $47,688 | $41,754 | $122,722 |
| Depreciation & Amortization | $33,522 | $184,325 | $149,508 | $147,519 |
| EBITDA | $40,358 | $127,671 | $233,885 | $251,833 |
| % Margin | 16.3% | 6.1% | 11.3% | 12.1% |